(Reuters) – The U.S. Food and Drug Administration on Wednesday removed boxed warning about amputation risk for Johnson & Johnson’s diabetes drug Invokana.
The agency’s harshest warning was part of the label as the FDA saw the risk of amputations was very serious.
( https://bit.ly/3jeJnh6)
(Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)
